Testicular cancer laboratory findings

Testicular cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Testicular cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Biopsy
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Testicular cancer laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Testicular cancer laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Testicular cancer laboratory findings
CDC on Testicular cancer laboratory findings
Testicular cancer laboratory findings in the news
Blogs on Testicular cancer laboratory findings
Directions to Hospitals Treating Testicular cancer
Risk calculators and risk factors for Testicular cancer laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

An elevated concentration of blood tumor marker tests is diagnostic of testicular cancer.

Laboratory Tests

Tumor marker tests

• Alpha-fetoprotein (AFP)
• Human chorionic gonadotropin (HCG)
• Lactate dehydrogenase (LDH)

References

Template:WikiDoc Sources